A Phase II, randomized, placebo-controlled, double-blind, multiple dose study to evaluate the Efficacy and Safety of ANB019 in subjects with Palmoplantar Pustulosis.


Register Today!

Let others know about this Trial!

Trial Information

Start DateFebruary 2020
Lead CRCAdam Pawluch
StatusIn Recruitment

For additional information
on this trial contact:

Phone705-566-0005